Loading...
512070 logo

UPL LimitedInforme acción BSE:512070

Capitalización bursátil ₹536.0b
Precio de las acciones
₹634.75
₹776.22
18.2% infravalorado descuento intrínseco
1Y-0.5%
7D0.7%
Valor de la cartera
Ver

UPL Limited

Informe acción BSE:512070

Capitalización de mercado: ₹536.0b

UPL (512070) Resumen de Acciones

UPL Limited, junto con sus filiales, se dedica al suministro de productos y soluciones de agricultura sostenible en India, Europa, Norteamérica, Latinoamérica y a escala internacional. Saber más

Análisis fundamental de 512070
Puntuación del snowflake
Valoración5/6
Crecimiento futuro3/6
Rendimiento pasado4/6
Salud financiera5/6
Dividendos4/6

512070 Community Fair Values

Create Narrative

See what 18 others think this stock is worth. Follow their fair value or set your own to get alerts.

Competidores de UPL Limited

Historial de precios y rendimiento

Resumen de las cotizaciones máximas, mínimas y variaciones del UPL
Precios históricos de las acciones
Precio actual de la acción₹634.75
Máximo en las últimas 52 semanas₹812.00
Mínimo de 52 semanas₹565.25
Beta0.58
Cambio en 1 mes-3.26%
Variación en 3 meses-16.96%
Cambio de 1 año-0.53%
Variación en 3 años-6.96%
Variación en 5 años-21.86%
Variación desde la OPV1,615.53%

Noticias y actualizaciones recientes

Actualización de narrativa May 18

512070: Upcoming Governance Meetings Will Support Stronger Medium Term Outlook

Analysts have trimmed their price target on UPL from ₹811.50 to ₹776.22, citing revised assumptions around profit margins, a higher future P/E multiple, and updated views on discount rates and revenue growth. What's in the News UPL has scheduled an Analyst/Investor Day, providing an opportunity to hear directly from management about the business and capital allocation plans.
Actualización de narrativa May 01

512070: Fair Pricing Will Depend On Execution Of Upcoming Restructuring And Treasury Plans

Analysts have trimmed their price target on UPL from ₹647.56 to ₹630.00, citing updated assumptions around revenue growth, profit margin, discount rate and future P/E that slightly adjust their valuation framework. What's in the News UPL has scheduled a Special or Extraordinary Shareholders Meeting on March 31, 2026, at 15:30 IST to consider and approve material related party transactions for sale of materials and functional support services between UPL and its subsidiaries, and between Arysta LifeScience Benelux SRL and UPL Europe Supply Chain GmbH (Key Developments).
Actualización de narrativa Apr 17

512070: Composite Scheme And Governance Steps Will Support Stronger Medium Term Outlook

Analysts have trimmed their price target on UPL slightly from about ₹820.53 to ₹811.50, reflecting updated assumptions around the discount rate, revenue growth, profit margin and future P/E multiple. What's in the News Board meeting on Feb 20, 2026 to consider a Composite Scheme of Arrangement among UPL Limited and multiple group entities under Sections 230 to 232 and 234 of the Companies Act, 2013, based on recommendations from the Audit Committee and the Committee of Independent Directors (company filing).
Actualización de narrativa Apr 03

512070: Upcoming Governance Decisions And Treasury Scheme Will Support A Stronger Outlook

Analysts have trimmed their price target on UPL from ₹975 to ₹947, citing updated assumptions on long term profit margins and P/E multiples, along with refreshed views on growth, discount rates and fair value. What's in the News UPL has called a Special or Extraordinary Shareholders Meeting for March 31, 2026, at 15:30 IST to seek approval for material related party transactions involving sale of materials and functional support services between UPL and its subsidiaries, and between Arysta LifeScience Benelux SRL and UPL Europe Supply Chain GmbH (Key Developments).

Recent updates

Actualización de narrativa May 18

512070: Upcoming Governance Meetings Will Support Stronger Medium Term Outlook

Analysts have trimmed their price target on UPL from ₹811.50 to ₹776.22, citing revised assumptions around profit margins, a higher future P/E multiple, and updated views on discount rates and revenue growth. What's in the News UPL has scheduled an Analyst/Investor Day, providing an opportunity to hear directly from management about the business and capital allocation plans.
Actualización de narrativa May 01

512070: Fair Pricing Will Depend On Execution Of Upcoming Restructuring And Treasury Plans

Analysts have trimmed their price target on UPL from ₹647.56 to ₹630.00, citing updated assumptions around revenue growth, profit margin, discount rate and future P/E that slightly adjust their valuation framework. What's in the News UPL has scheduled a Special or Extraordinary Shareholders Meeting on March 31, 2026, at 15:30 IST to consider and approve material related party transactions for sale of materials and functional support services between UPL and its subsidiaries, and between Arysta LifeScience Benelux SRL and UPL Europe Supply Chain GmbH (Key Developments).
Actualización de narrativa Apr 17

512070: Composite Scheme And Governance Steps Will Support Stronger Medium Term Outlook

Analysts have trimmed their price target on UPL slightly from about ₹820.53 to ₹811.50, reflecting updated assumptions around the discount rate, revenue growth, profit margin and future P/E multiple. What's in the News Board meeting on Feb 20, 2026 to consider a Composite Scheme of Arrangement among UPL Limited and multiple group entities under Sections 230 to 232 and 234 of the Companies Act, 2013, based on recommendations from the Audit Committee and the Committee of Independent Directors (company filing).
Actualización de narrativa Apr 03

512070: Upcoming Governance Decisions And Treasury Scheme Will Support A Stronger Outlook

Analysts have trimmed their price target on UPL from ₹975 to ₹947, citing updated assumptions on long term profit margins and P/E multiples, along with refreshed views on growth, discount rates and fair value. What's in the News UPL has called a Special or Extraordinary Shareholders Meeting for March 31, 2026, at 15:30 IST to seek approval for material related party transactions involving sale of materials and functional support services between UPL and its subsidiaries, and between Arysta LifeScience Benelux SRL and UPL Europe Supply Chain GmbH (Key Developments).
Actualización de narrativa Mar 19

512070: Fair Pricing Will Rely On Execution Of Upcoming Restructuring Steps

Analysts have nudged their price target on UPL slightly higher to about ₹648 from roughly ₹641, citing updated assumptions around revenue growth, profit margins, a modestly lower discount rate, and a small adjustment to the expected future P/E multiple. What's in the News UPL has scheduled a board meeting on Feb 02, 2026 at 12:45 Indian Standard Time to consider and approve unaudited consolidated and standalone financial results for the quarter and nine months ended Dec 31, 2025, along with limited review reports from the statutory auditors (Key Developments).
Actualización de narrativa Mar 05

512070: Composite Scheme Board Meeting Will Support Stronger Medium Term Outlook

Analysts have raised their price target on UPL by about ₹39 to ₹820, citing updated assumptions that reflect a slightly lower discount rate, a modest tweak to revenue growth and P/E expectations, and a higher projected profit margin. What's in the News Board meeting scheduled for Feb 20, 2026 at 14:30 IST to consider a Composite Scheme of Arrangement involving UPL and its subsidiaries UPL Sustainable Agri Solutions Limited, UPL Global Sustainable Agri Solutions Limited, and UPL Crop Protection Holdings Limited under Sections 230 to 232 and 234 of the Companies Act, 2013 (company filing).
Actualización de narrativa Feb 18

512070: Revised Margins And Lower P/E Will Likely Struggle To Support Pricing

Analysts have raised their fair value estimate for UPL from ₹600.67 to ₹641.03, citing updated views on the discount rate, revenue growth, profit margins and future P/E assumptions. What's in the News Board meeting scheduled for Feb 02, 2026, at 12:45 Indian Standard Time to review unaudited consolidated and standalone financial results for the quarter and nine months ended Dec 31, 2025 (Key Developments).
Actualización de narrativa Feb 04

512070: Higher Margin Assumptions And Upcoming Results Will Support A Stronger Fair Value Outlook

Analysts have raised their fair value estimate for UPL from ₹944 to ₹975, reflecting updated assumptions around discount rate, revenue growth, profit margin, and future P/E expectations. What's in the News UPL has scheduled a board meeting on Feb 02, 2026, at 12:45 Indian Standard Time to review unaudited consolidated and standalone financial results.
Actualización de narrativa Jan 21

512070: Higher Revenue And Margin Assumptions Will Support A Stronger Fair Value Outlook

Analysts have raised their fair value estimate for UPL from ₹911.93 to ₹944.00 after updating their assumptions for revenue growth, profit margins, discount rate and future P/E. What's in the News UPL has scheduled a Board Meeting on November 6, 2025 to consider and approve the unaudited consolidated and standalone financial results for the quarter and half year ended September 30, 2025, along with the Limited Review Reports from the statutory auditors (company filing).
Actualización de narrativa Jan 07

512070: Small Assumption Tweaks Will Likely Fail To Prevent Margin Pressure

Analysts have slightly increased their fair value estimate for UPL from ₹596.98 to ₹600.67. This reflects small adjustments to assumptions around the discount rate, revenue growth, profit margins and future P/E multiples.
Actualización de narrativa Dec 19

512070: Future Margins Will Likely Deteriorate Despite Higher Market Expectations

Analysts have raised their price target for UPL from approximately 526.51 to 596.98, citing slightly stronger expectations for revenue growth and future valuation multiples, partly offset by a more conservative view on profit margins and discount rates. What's in the News UPL Limited has scheduled a board meeting for November 06, 2025 to consider and approve unaudited consolidated and standalone financial results for the quarter and half year ended September 30, 2025, along with the limited review reports from the statutory auditors (company filing).
Actualización de narrativa Dec 05

512070: Board Meeting And Stable Assumptions Will Shape Medium Term Outlook

Analysts have modestly raised their price target for UPL to ₹781.39, reflecting slightly improved discount rate and future P E assumptions, while largely maintaining their views on growth and profitability. What's in the News A board meeting is scheduled on November 6, 2025 to consider and approve the unaudited consolidated and standalone financial results for the quarter and half year ended September 30, 2025, along with the Statutory Auditors' limited review reports (company filing).
Actualización de narrativa Nov 21

512070: Board Meetings And Adjusted Forecasts Will Influence Medium-Term Outlook

Analysts have raised their price target for UPL from $756.34 to $781.39. This reflects optimism driven by slightly improved revenue growth expectations and adjustments to projected profit margins and valuation multiples.
Actualización de narrativa Nov 07

512070: Upcoming Board Decisions And Steady Financials Will Shape Outlook

Analysts have raised their price target for UPL from $736.09 to $756.34. They cite modest improvements in profit margin and revenue growth forecasts as the reason for this adjustment.
User avatar
Nueva narrativa Dec 10

Biosolutions Innovation And Improved Financial Stability Expected To Boost Earnings Growth

Strategic inventory management and sales mix enhancement are expected to boost margins and improve earnings.

Rentabilidad de los accionistas

512070IN ChemicalsMercado IN
7D0.7%0.7%0.5%
1Y-0.5%-2.6%-0.7%

Rentabilidad vs. Industria: 512070 superó a la industria Indian Chemicals, que obtuvo un rendimiento del -2.6% el año pasado.

Rentabilidad vs. Mercado: 512070 igualó el mercado Indian, que obtuvo un rendimiento del -0.7% el año pasado.

Volatilidad de los precios

Is 512070's price volatile compared to industry and market?
512070 volatility
512070 Average Weekly Movement6.4%
Chemicals Industry Average Movement7.2%
Market Average Movement7.2%
10% most volatile stocks in IN Market10.1%
10% least volatile stocks in IN Market4.8%

Precio estable de las acciones: 512070 no ha tenido una volatilidad de precios significativa en los últimos 3 meses en comparación con el mercado Indian.

Volatilidad a lo largo del tiempo: La volatilidad semanal de 512070 (6%) se ha mantenido estable durante el año pasado.

Acerca de la empresa

FundadaEmpleadosCEOPágina web
196912,000Jai Shroffwww.upl-ltd.com

UPL Limited, junto con sus filiales, se dedica al suministro de productos y soluciones de agricultura sostenible en India, Europa, Norteamérica, Latinoamérica e internacionalmente. Opera a través de tres segmentos: Protección de Cultivos, Negocio de Semillas y No Agrícola. El segmento de Protección de Cultivos suministra herbicidas, fungicidas, insecticidas, acaricidas, productos para el tratamiento de semillas, adyuvantes, biosoluciones, productos de salud pública, fumigantes y soluciones postcosecha, así como ProNutiva, una solución para la protección de cultivos.

Resumen de fundamentos de UPL Limited

¿Cómo se comparan los beneficios e ingresos de UPL con su capitalización de mercado?
Estadísticas fundamentales de 512070
Capitalización bursátil₹536.00b
Beneficios(TTM)₹19.22b
Ingresos (TTM)₹518.39b
27.9x
Ratio precio-beneficio (PE)
1.0x
Ratio precio-ventas (PS)

¿Está 512070 sobrevalorada?

Ver valor justo y análisis de valoración

Beneficios e Ingresos

Estadísticas clave de rentabilidad del último informe de resultados (TTM)
Cuenta de resultados (TTM) de 512070
Ingresos₹518.39b
Coste de los ingresos₹258.91b
Beneficio bruto₹259.48b
Otros gastos₹240.26b
Beneficios₹19.22b

Últimos beneficios comunicados

Mar 31, 2026

Próxima fecha de beneficios

n/a

Beneficios por acción (BPA)22.76
Margen bruto50.06%
Margen de beneficio neto3.71%
Ratio deuda/patrimonio53.4%

¿Cómo se ha desempeñado 512070 a largo plazo?

Ver rendimiento histórico y comparativa

Dividendos

0.9%
Rentabilidad actual por dividendo
27%
Ratio de pagos

Análisis de la empresa y estado de los datos financieros

DatosÚltima actualización (huso horario UTC)
Análisis de la empresa2026/05/20 05:13
Precio de las acciones al final del día2026/05/20 00:00
Beneficios2026/03/31
Ingresos anuales2026/03/31

Fuentes de datos

Los datos utilizados en nuestro análisis de empresas proceden de S&P Global Market Intelligence LLC. Los siguientes datos se utilizan en nuestro modelo de análisis para generar este informe. Los datos están normalizados, lo que puede introducir un retraso desde que la fuente está disponible.

PaqueteDatosMarco temporalEjemplo Fuente EE.UU. *
Finanzas de la empresa10 años
  • Cuenta de resultados
  • Estado de tesorería
  • Balance
Estimaciones del consenso de analistas+3 años
  • Previsiones financieras
  • Objetivos de precios de los analistas
Precios de mercado30 años
  • Precios de las acciones
  • Dividendos, escisiones y acciones
Propiedad10 años
  • Accionistas principales
  • Información privilegiada
Gestión10 años
  • Equipo directivo
  • Consejo de Administración
Principales avances10 años
  • Anuncios de empresas

* Ejemplo para valores de EE.UU., para no EE.UU. se utilizan formularios y fuentes normativas equivalentes.

A menos que se especifique lo contrario, todos los datos financieros se basan en un periodo anual, pero se actualizan trimestralmente. Esto se conoce como datos de los últimos doce meses (TTM) o de los últimos doce meses (LTM). Más información.

Modelo de análisis y copo de nieve

Los detalles del modelo de análisis utilizado para generar este informe están disponibles en nuestra página de Github, también tenemos guías sobre cómo utilizar nuestros informes y tutoriales en Youtube.

Conozca al equipo de talla mundial que diseñó y construyó el modelo de análisis Simply Wall St.

Métricas industriales y sectoriales

Simply Wall St calcula cada 6 horas nuestras métricas sectoriales y de sección. Los detalles de nuestro proceso están disponibles en Github.

Fuentes analistas

UPL Limited está cubierta por 40 analistas. 17 de esos analistas presentaron las estimaciones de ingresos o ganancias utilizadas como datos para nuestro informe. Las estimaciones de los analistas se actualizan a lo largo del día.

AnalistaInstitución
null null360 ONE Capital Market Private Limited
null nullAnand Rathi Shares and Stock Brokers Limited
Himanshu BinaniAnand Rathi Shares and Stock Brokers Limited